tiprankstipranks
InMed Pharmaceuticals (INM)
NASDAQ:INM
US Market

InMed Pharmaceuticals (INM) Income Statement

Compare
343 Followers

InMed Pharmaceuticals Income Statement

Last quarter (Q2 2025), InMed Pharmaceuticals's total revenue was $1.11B, an increase of 89539.33% from the same quarter last year. In Q2, InMed Pharmaceuticals's net income was $-2.58B. See InMed Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
$ 4.60M$ 4.14M$ 1.09M$ 0.00$ 0.00
Gross Profit
$ 1.10M$ 1.40M$ 543.55K$ -197.03K$ -183.09K
Operating Expenses
$ 9.02B$ 9.78M$ 14.34M$ 9.94M$ 8.87M
Depreciation and Amortization
$ 604.52K$ 596.00K$ 511.79K$ 197.03K$ 183.09K
EBITDA
$ -7.06M$ -10.83M$ -17.26M$ -9.80M-
Operating Income
$ 0.00$ -8.18B$ -13.70M$ -9.92M-
Other Income/Expenses
$ 246.38M$ 588.53K$ -1.10M$ 2.12M$ 60.73K
Pretax Income
$ -7.67M$ -7.93M$ -18.60M$ -10.20M-
Net Income
$ -7.68M$ -7.95M$ -18.60M$ -10.20M$ -8.94M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.01$ -3.25$ -33.17$ -37.78$ -42.57
Diluted EPS
$ -1.01$ -3.25$ -33.17$ -37.78$ -42.57
Weighted Average Shares Outstanding
7.62M 2.45M 560.75K 270.00K 210.00K
Weighted Average Shares Outstanding (Diluted)
7.62M 2.45M 560.83K 270.00K 210.00K
Currency in USD

InMed Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis